|
Learn from Dr Andy Forreryd how GARD™ and other in vitro assays can be used to fill data gaps in sensitizing hazard and potency assessment of chemicals. Read more |
|
|
|
Our Chief Scientist Dr Henrik Johansson will present the latest development on GARD™skin Dose-Response, our novel in vitro assay for quantitative skin sensitizing potency assessment. Read more |
|
|
March 23 at 1:00pm EDT | # P323 | View Quantitative Sensitizing Potency Assessment Using GARD™skin Dose-Response
March 23 at 1:00pm EDT| # P322 | View GARD™skin and GARD™potency: A Proof-of-Concept Study to Investigate the Applicability Domain for Agrochemical Formulations
March 24 at 11:15am EDT | # P158 | View Applicability Domain of the GARD™skin Medical Device Test for In Vitro Skin Sensitization Testing of Medical Devices 🏅 |
|
|